How many insider trades does FilingIQ track for CNXU?

FilingIQ tracks 5 Form 4 insider transactions for CNXU (Conexeu Sciences Inc.), covering filings from May 14, 2026 onwards. 2 of those were filed in the last 90 days.

Are CNXU insiders net buyers or net sellers?

Across the full Form 4 history for CNXU, 1 transactions (20%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CNXU insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CNXU in?

Conexeu Sciences Inc. (CNXU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $252.33M.

CNXU insider trading

NasdaqCM Healthcare

Conexeu Sciences Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

20% / 0%

Market cap

$252.33M

About Conexeu Sciences Inc.

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Company website: www.conexeu.com

CNXU insider activity at a glance

FilingIQ has scored 5 insider transactions for CNXU since May 14, 2026. The most recent filing in our index is dated Jun 18, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CNXU insider trades is 53.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CNXU trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 827

UNITED THERAPEUTICS Corp

BLLN 169

BillionToOne, Inc.

KYMR 167

Kymera Therapeutics, Inc.

Guardant Health, Inc.

OMDA 109

Omada Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for CNXU?: FilingIQ tracks 5 Form 4 insider transactions for CNXU (Conexeu Sciences Inc.), covering filings from May 14, 2026 onwards. 2 of those were filed in the last 90 days.
Are CNXU insiders net buyers or net sellers?: Across the full Form 4 history for CNXU, 1 transactions (20%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CNXU insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CNXU in?: Conexeu Sciences Inc. (CNXU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $252.33M.

Methodology & sources

Every CNXU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.